Alyeska Investment Group
ATRC icon

Alyeska Investment Group’s AtriCure ATRC Stock Holding History

Alyeska Investment Group’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-45,625
Closed -$672K – 483
2014
Q3 		$672K Sell
45,625
-207,282
-82% -$3.3M 0.01% 351
2014
Q2 		$4.65M Buy
252,907
+3,597
+1% +$59.9K 0.1% 239
2014
Q1 		$4.69M Buy
+249,310
New +$5.11M 0.13% 201
2013
Q4 		– Sell
-215,737
Closed -$2.37M – 303
2013
Q3 		$2.37M Buy
215,737
+50,000
+30% +$493K 0.1% 211
2013
Q2 		$1.57M Buy
+165,737
New +$1.44M 0.08% 215

Other funds holding ATRC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alyeska Investment Group's ATRC Position: Q4 2014 in Review

Alyeska Investment Group sold out of AtriCure (ATRC) in Q4 2014, closing a stake of 45,625 shares — an estimated $672K sold.

Alyeska Investment Group first reported a position in ATRC in Q2 2013 and held it in 5 quarters. The position peaked at $4.69M in Q1 2014. 105 funds tracked by Wall St. Rank hold ATRC as of Q4 2014.

  • Alyeska Investment Group reported no remaining AtriCure position as of Q4 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 45,625 AtriCure shares in Q4 2014, an estimated $672K.
  • Alyeska Investment Group first reported a position in AtriCure in Q2 2013 and held it in 5 quarters.
  • Alyeska Investment Group's AtriCure position peaked at $4.69M in Q1 2014.
  • 105 funds tracked by Wall St. Rank held AtriCure as of Q4 2014.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.